Keith Berman, MPH, MBA
ConsultantHealth Research Associates
Keith Berman, MPH, MBA, founded Health Research Associates in 1996. HRA provides reimbursement consulting, business development and market research services to leading biopharmaceuticals, blood products and medical device manufacturers and suppliers. Previously, Mr. Berman worked for ten years in product development, reimbursement development, and market research roles at Baxter Healthcare, Siemens Medical, and MiniMed Technologies (now a Medtronic division). Since 1989, he has also served as editor of International Blood/Plasma News, an blood products industry newsletter. (This is me - Update Profile)
| 1996 - present | Consultant Health Research Associates |
|---|
GLG Study Groups with Keith Berman, MPH, MBA(?)
| Study Group Name | Members |
|---|---|
| Economic Experts on Managed Care | 630 |
| Medicare Experts | 429 |
GLG NewsSM Analyses by Keith Berman, MPH, MBA(?)
After abandoning a 2007 IPO, Talecris majority owner Cerberus Capital is now reported to be pursuing negotiations to sell the $1.2 billion plasma products firm. Talecris' valuation will necessarily involve projections of worldwide market demand for intravenous immunoglobulin (IVIg), the industry's most...
If a report in the Financial Times is credible, the already consolidating plasma products industry could render down to even fewer players in the near future with the sale of Talecris to a major competitor. The value of the company will be strongly influenced by the direction in demand for its industry's...
The FDA -- likely with encouragement of King Pharmaceuticals -- has ordered ZymoGenetics to cease dissemination of materials that cite "a significantly lower incidence of antibody formation compared to the commercially available bovine thrombin product [Thrombin-JMI]." "This statement is false or misleading...
Three presentations at this week's AAN meeting in Chicago are adding in a big way to accumulating evidence that intravenous immunoglobulin (IVIg) may slow, halt or even PREVENT accumulation of toxic beta-amyloid -- a prime culprit in the development of Alzheimer's disease (AD) in millions of aging individuals....
GLG InstituteSM Seminars with Keith Berman, MPH, MBA(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Keith Berman, MPH, MBA
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

